e-Pedigree 소프트웨어 시장 보고서 : 구성요소별, 전개 방식별, 기업 규모별, 용도별, 지역별(2025-2033년)

The global epedigree software market size reached USD 5.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 16.8 Billion by 2033, exhibiting a growth rate (CAGR) of 12.37% during 2025-2033. The increasing need for serializability, integration of advanced technologies, and the expansion of e-commerce platforms in the pharmaceutical sector represent some of the key factors driving the market.

Epedigree software keeps an electronic record of changes in the ownership of a pharmaceutical product for drug authentication. It allows a single view of the product and order and aids in protecting consumers from contaminated medicine and counterfeit drugs. It provides a high level of accuracy, protects brand value, enhances operational efficiency, guarantees compliance, and lowers labor and inventory costs. It is easy and fast to implement, improves the pharmaceutical supply chain security, and delivers the lowest total cost of pedigree management. At present, the expansion of e-commerce platforms in the pharmaceutical sector on account of rapid digitization, increasing internet connectivity, and the rising penetration of smart devices is driving the demand for epedigree software across the globe.

Epedigree Software Market Trends:

The rising need for serializability to tackle counterfeiting represents one of the major factors increasing the demand for epedigree software around the world. Moreover, the rising adoption of epedigree software by various clinical research and outsourcing companies is favoring the market growth. In addition, stringent regulations imposed by regulatory authorities like federal agencies, governments, and pharmaceutical companies to reduce drug fabricating and product diversion are contributing to the market growth. Apart from this, there is an increase in demand for smartening and securing the overall pharma supply chain. This, coupled with the rising integrating of advanced technologies, including quick response (QR) codes, barcodes, cloud computing, advanced analytics, big data, and radio frequency identification (RFID), the internet of things (IoT) with pharma supply chain, is impelling the market growth. Key players are incorporating virtual assistants, augmented reality (AR), machine learning (ML), and virtual reality (VR) to support the appropriation of cutting-edge systems across the supply chain network and pharma productions. These technological solutions assist in the processing of a pharmaceutical drug from manufacturing and distribution until the drug reaches the consumer. They also enable better stock management and lead to the reduction in costs incurred in terms of inventory maintenance, wastage of products, and storage of drugs. Furthermore, the incorporation of cloud-based solutions and blockchain technology for making the whole supply chain smarter and more efficient with end-to-end quality control solutions is influencing the market positively. Besides this, the growing necessity to maintain the integrity of the complex pharma supply chain is creating a positive outlook for the market.

Key Market Segmentation:

Component Insights:

• Software
• Services

Deployment Type Insights:

• On-premises
• Cloud-based

Enterprise Size Insights:

• Small and Medium-sized Enterprises
• Large Enterprises

Application Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Pharmaceutical Factory
• Online Pharmacies
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for epedigree software. Some of the factors driving the North America epedigree software market included a considerable reliance on e-commerce platforms, a rising number of clinical researches, and stringent regulations imposed by governing authorities to reduce drug fabricating and product diversion.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global epedigree software market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Antares Vision Spa, Axway, SAP SE, and TraceLink Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. How big is the global epedigree software market?
• 2. What is the expected growth rate of the global epedigree software market during 2025-2033?
• 3. What are the key factors driving the global epedigree software market?
• 4. What has been the impact of COVID-19 on the global epedigree software market?
• 5. What is the breakup of the global epedigree software market based on the deployment type?
• 6. What is the breakup of the global epedigree software market based on the enterprise size?
• 7. What is the breakup of the global epedigree software market based on the application?
• 8. What are the key regions in the global epedigree software market?
• 9. Who are the key players/companies in the global epedigree software market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Epedigree Software Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Component

• 6.1 Software
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Deployment Type

• 7.1 On-premises
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cloud-based
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Enterprise Size

• 8.1 Small and Medium-sized Enterprises
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Large Enterprise
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Application

• 9.1 Hospital Pharmacies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Retail Pharmacies
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Pharmaceutical Factory
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Online Pharmacies
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Others
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

• 11.1 Overview
• 11.2 Drivers
• 11.3 Restraints
• 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Antares Vision Spa
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
  • 15.3.2 Axway
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 SAP SE
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 TraceLink Inc.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report